275 related articles for article (PubMed ID: 27621205)
1. Abundance of Drug Transporters in the Human Kidney Cortex as Quantified by Quantitative Targeted Proteomics.
Prasad B; Johnson K; Billington S; Lee C; Chung GW; Brown CD; Kelly EJ; Himmelfarb J; Unadkat JD
Drug Metab Dispos; 2016 Dec; 44(12):1920-1924. PubMed ID: 27621205
[TBL] [Abstract][Full Text] [Related]
2. Renal tubular secretion of tanshinol: molecular mechanisms, impact on its systemic exposure, and propensity for dose-related nephrotoxicity and for renal herb-drug interactions.
Jia W; Du F; Liu X; Jiang R; Xu F; Yang J; Li L; Wang F; Olaleye OE; Dong J; Li C
Drug Metab Dispos; 2015 May; 43(5):669-78. PubMed ID: 25710938
[TBL] [Abstract][Full Text] [Related]
3. Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes.
Uchida Y; Goto R; Takeuchi H; Łuczak M; Usui T; Tachikawa M; Terasaki T
Drug Metab Dispos; 2020 Feb; 48(2):135-145. PubMed ID: 31771948
[TBL] [Abstract][Full Text] [Related]
4. Kidney Cortical Transporter Expression across Species Using Quantitative Proteomics.
Basit A; Radi Z; Vaidya VS; Karasu M; Prasad B
Drug Metab Dispos; 2019 Aug; 47(8):802-808. PubMed ID: 31123036
[TBL] [Abstract][Full Text] [Related]
5. Precise comparison of protein localization among OCT, OAT, and MATE in human kidney.
Motohashi H; Nakao Y; Masuda S; Katsura T; Kamba T; Ogawa O; Inui K
J Pharm Sci; 2013 Sep; 102(9):3302-8. PubMed ID: 23630107
[TBL] [Abstract][Full Text] [Related]
6. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
Müller F; König J; Hoier E; Mandery K; Fromm MF
Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
[TBL] [Abstract][Full Text] [Related]
7. The interactions of lenalidomide with human uptake and efflux transporters and UDP-glucuronosyltransferase 1A1: lack of potential for drug-drug interactions.
Tong Z; Yerramilli U; Surapaneni S; Kumar G
Cancer Chemother Pharmacol; 2014 Apr; 73(4):869-74. PubMed ID: 24627218
[TBL] [Abstract][Full Text] [Related]
8. Raltegravir has a low propensity to cause clinical drug interactions through inhibition of major drug transporters: an in vitro evaluation.
Rizk ML; Houle R; Chan GH; Hafey M; Rhee EG; Chu X
Antimicrob Agents Chemother; 2014; 58(3):1294-301. PubMed ID: 24295974
[TBL] [Abstract][Full Text] [Related]
9. Gestational Age-Dependent Abundance of Human Placental Transporters as Determined by Quantitative Targeted Proteomics.
Anoshchenko O; Prasad B; Neradugomma NK; Wang J; Mao Q; Unadkat JD
Drug Metab Dispos; 2020 Sep; 48(9):735-741. PubMed ID: 32591415
[TBL] [Abstract][Full Text] [Related]
10. Renal Drug Transporters and Drug Interactions.
Ivanyuk A; Livio F; Biollaz J; Buclin T
Clin Pharmacokinet; 2017 Aug; 56(8):825-892. PubMed ID: 28210973
[TBL] [Abstract][Full Text] [Related]
11. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human kidney drug transporters.
Han YH; Busler D; Hong Y; Tian Y; Chen C; Rodrigues AD
Drug Metab Dispos; 2010 Jul; 38(7):1064-71. PubMed ID: 20360303
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of the mRNA Expression of Human Renal Drug Transporters by Proinflammatory Cytokines in Primary Human Proximal Tubular Epithelial Cells.
Tsang YP; Hao T; Mao Q; Kelly EJ; Unadkat JD
Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399338
[TBL] [Abstract][Full Text] [Related]
13. Protein Abundance of Clinically Relevant Drug Transporters in The Human Kidneys.
Oswald S; Müller J; Neugebauer U; Schröter R; Herrmann E; Pavenstädt H; Ciarimboli G
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653114
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Analysis of Ontogeny of Renal Drug Transporters: mRNA Analyses, Quantitative Proteomics, and Localization.
Cheung KWK; van Groen BD; Spaans E; van Borselen MD; de Bruijn ACJM; Simons-Oosterhuis Y; Tibboel D; Samsom JN; Verdijk RM; Smeets B; Zhang L; Huang SM; Giacomini KM; de Wildt SN
Clin Pharmacol Ther; 2019 Nov; 106(5):1083-1092. PubMed ID: 31127606
[TBL] [Abstract][Full Text] [Related]
15. Membrane transport function in primary cultures of human proximal tubular cells.
Lash LH; Putt DA; Cai H
Toxicology; 2006 Dec; 228(2-3):200-18. PubMed ID: 16997449
[TBL] [Abstract][Full Text] [Related]
16. Quantification of Four Efflux Drug Transporters in Liver and Kidney Across Species Using Targeted Quantitative Proteomics by Isotope Dilution NanoLC-MS/MS.
Fallon JK; Smith PC; Xia CQ; Kim MS
Pharm Res; 2016 Sep; 33(9):2280-8. PubMed ID: 27356525
[TBL] [Abstract][Full Text] [Related]
17. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Toxicokinetics Roles of Membrane Transporters at Kidney Level.
Veiga-Matos J; Remião F; Motales A
J Pharm Pharm Sci; 2020; 23():333-356. PubMed ID: 32997956
[TBL] [Abstract][Full Text] [Related]
19. Mirogabalin, a novel α
Yamamura N; Mikkaichi T; Itokawa KI; Hoshi M; Damme K; Geigner S; Baumhauer C
Xenobiotica; 2022; 52(9-11):997-1009. PubMed ID: 36170033
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Targeted Absolute Proteomics for 28 Transporters in Brush-Border and Basolateral Membrane Fractions of Rat Kidney.
Uchida Y; Toyohara T; Ohtsuki S; Moriyama Y; Abe T; Terasaki T
J Pharm Sci; 2016 Feb; 105(2):1011-1016. PubMed ID: 26367854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
